Intermittent androgen deprivation therapy in advanced prostate cancer.
about
Hormone naïve prostate cancer: predicting and maximizing response intervalsPredicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data.IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer.Employing dynamical computational models for personalizing cancer immunotherapy.STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer.Androgen deprivation and immunotherapy for the treatment of prostate cancer
P2860
Intermittent androgen deprivation therapy in advanced prostate cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Intermittent androgen deprivation therapy in advanced prostate cancer.
@en
type
label
Intermittent androgen deprivation therapy in advanced prostate cancer.
@en
prefLabel
Intermittent androgen deprivation therapy in advanced prostate cancer.
@en
P2860
P1476
Intermittent androgen deprivation therapy in advanced prostate cancer.
@en
P2093
Ajjai Alva
Maha Hussain
P2860
P2888
P304
P356
10.1007/S11864-013-0272-2
P577
2014-03-01T00:00:00Z
P6179
1050231548